Related to Takara Bio Taps University of Pennsylvania to Help Advance HIV Gene Therapy into U.S. Clinical Investigations

• GeoVax Labs Receives $0.8M Funding Boost from NIAID to Progress HIV Vaccine
  
• FKD Therapies Acquires Exclusive License to Merck & Co.’s Gene Therapy Portfolio
  
• Investigators Figure Out One Way to Stop HIV from Dampening Adaptive Immune Response
  
• Gilead Negotiates Worldwide License to BI’s Early Clinical Stage HIV Program
  
• Binding of Potent Neutralizing Antibody to HIV Hints at New Vaccine Targets
  
• RetroSense Licenses Gene Therapy for Restoring Vision from Wayne State University
  
• GeoVax and Vivalis Sign Deal for the Biomanufacture of MVA HIV Vaccine in EB66 Cells
  
• Oxford BioMedica and Mayo Clinic Partner to Develop Gene Therapy for Glaucoma
  
• Gilead and Tibotec Expand HIV Drug Development Arrangement
  
• Structure of Key HIV Glycoprotein Domain Unveiled
  
• EC Clears Gilead’s Single-Pill Triple-Drug HIV-1 Therapy
  
• Nearly Two-to-One Majority Sees FDA or EMA Approval of Gene Therapy by 2013
  
• Research Teams Independently Identify New HIV-1 Target
  
• FDA Sanctions Merck & Co.’s Isentress for Use in HIV-1 Children, Teens
  
• AMT Raises €2.5M but Says Future Still Hangs in the Balance
  
• Gilead Wins Sanction in the U.S. for Viread in HIV-Infected Children
  
• Siemens Seals Companion Dx Deals with ViiV and Tocagen for HIV and Brain Cancer Candidates
  
• Host Cells Starve HIV-1 of Building Blocks to Prevent Viral Replication
  
• Gene Therapy Shows Promise for Treating Beta-Thalassemia and Sickle Cell Disease
  
• Engineered HSCs Differentiate into HIV-Specific CTLs that Hold Back HIV Infection In Vivo